معرفی
Professor Richelle Mychasiuk is a faculty member within the Department of Neuroscience at Monash University's School of Translational Medicine. She leads a laboratory focused on neurodevelopmental plasticity, particularly examining how early environmental factors (stress, diet, drug exposure) influence brain development and recovery from injury. Her work also addresses chronic pain mechanisms and mental health risks, with collaborations in the GIN initiative (Gastroenterology-Immunology-Neuroscience) to study the gut-brain-immune axis. Mychasiuk has secured significant funding including an NHMRC EL2 Investigator Grant ($1.45M), CIHR grants, and commercial partnerships. Awards include the Health Science Research Mentor Award (Calgary) and Monash's Dean’s Award for Diversity & Inclusion (2022).
Education:
- PhD in Neuroscience (2012)
- Masters in Forensic Molecular Biology (2007)
- BSc in Psychology (2005)
- BSc in Cellular/Molecular Microbial Biology (2005)
Research Focus:
Her lab employs behavioral, epigenetic, and imaging techniques to investigate:
- Post-TBI circadian system disruption and immune interactions
- Acute-to-chronic pain transition mechanisms
- Orexxin modulation's role in glymphatic clearance and sleep recovery
- Environmental interventions (diet, feeding rhythms) on TBI outcomes
Grants & Funding:
- Lead investigator: NHMRC EL2 Grant ($1.45M), CIHR ($1.2M)
- Co-PI on $3M+ NHMRC Ideas grants (neurological TBI consequences, abusive head injury)
- Commercial partnerships: $1.1M+ (Incannex Healthcare, Eisai Inc)
Projects:
- Preclinical models for neonatal abusive head trauma
- Intimate partner violence brain injury insights
- Cannabidiol/isoflurane neuroprotection in mild TBI
Labs/Teams:
Monash Trauma Group (website: link) focuses on translational research from bench to bedside.
